Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000882691 | SCV001025948 | benign | not provided | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000882691 | SCV001939056 | benign | not provided | 2020-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260096 | SCV002539522 | benign | Bohring-Opitz syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002260096 | SCV003825153 | uncertain significance | Bohring-Opitz syndrome | 2019-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004550020 | SCV004779962 | likely benign | ASXL1-related disorder | 2019-02-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |